Cholera vaccines Market Overview and Competitive Analysis -Astellas Pharma Inc., AstraZeneca, Emergent BioSolutions Inc., GlaxoSmithKline plc (GSK)

By: X herald

Cholera vaccines Market – Growth, Trends, And Forecast (2019 – 2024)

The report presents an in-depth assessment of the Cholera vaccines including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles, and strategies. The report also presents forecasts for Cholera vaccine investments from 2019 till 2024.

The Cholera vaccines market is highly competitive and consists of a number of major players. Top Companies like Astellas Pharma Inc., AstraZeneca, Emergent BioSolutions Inc., GlaxoSmithKline plc (GSK), Merck & Co. Inc., Mitsubishi Tanabe Pharma Corporation, PaxVax Inc., Pfizer Inc., Shantha Biotechnics Private Limited, Takeda Pharmaceutical Co. Ltd, Valneva SE among others

Click the link to get a Sample Copy of the Report:

https://www.marketinsightsreports.com/reports/08071391833/cholera-vaccines-market-growth-trends-and-forecast-2019-2024/inquiry?source=MW&Mode=70

Scope of the Report

Cholera is caused by Vibrio cholerae via the consumption of contaminated food or water. The infected individuals suffer from severe watery diarrhea, eventually leading to dehydration, which if unattended, may lead to death, owing to access water loss. Oral vaccination has been observed to be the best preventive treatment for cholera and has proved to be very useful to prevent huge outbreaks. There are two basic types of vaccines given for cholera: whole-cell V. cholerae O1, in combination with a recombinant B-subunit of cholera toxin (WC/rBS), and killed oral O1 and O139.

Key Market Trends

Whole-cell V. cholerae O1 with a Recombinant B-subunit Segment Captures the Largest Market Share.

This oral cholera vaccine containing a combination of recombinant B-subunit and killed the whole-cell V. cholerae O1 has been marketed since early 1990. This vaccine is observed to provide 80-90% protection for six months, post-immunization, and in all the cases of immunization of vaccines aged more than 2 years. In addition to this, this vaccine shows around 50% of protection even after three years of immunization. Hence, the efficacy and long-lasting post-immunization protections of the vaccine are expected to propel the growth of the segments over the forecast period.

North America is Expected to Grow at a High Rate over the Forecast Period

Asia-Pacific captures the largest market share in the global cholera vaccines market, followed by Europe. This can be attributed to the high incidence rate, growing awareness, and availability of efficient preventive solutions. The APAC market experienced exceptional growth since the launch of the oral cholera vaccine, Shanchol, in 2009. According to the statistics of WHO, 42 countries reported 172,454 cases of cholera in 2015, with 1,304 deaths. These statistics showed an overall decrease of 9% from the previous year, owing to growing immunization in the region. On the other hand, North America is expected to exhibit the fastest growth rate over the forecast period, owing to the launch of the first-ever oral cholera vaccine, Vaxchora, is 2016, and the rise in the number of immigrants.

Browse the Full report description and TOC at:

https://www.marketinsightsreports.com/reports/08071391833/cholera-vaccines-market-growth-trends-and-forecast-2019-2024?source=MW&Mode=70

What are the market factors that are explained in the report?

–Key Strategic Developments: The study also includes the key strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a global and regional scale.

–Key Market Features: The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.

–Analytical Tools: Cholera vaccines Market report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porter’s five forces analysis, feasibility study, and investment return analysis have been used to analyzed the growth of the key players operating in the market.

The research includes historic data from 2014 to 2019 and forecasts until 2025 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.

Media Contact Us:

Irfan Tamboli (Head of Sales) – Market Insights Reports

Phone: + 1704 266 3234 | +91-750-707-8687

sales@marketinsightsreports.com | irfan@marketinsightsreports.com

 

 

This Press Release has been written with the intention of providing accurate market information which will enable our readers to make informed strategic investment decisions. If you notice any problem with this content, please feel free to reach us on mediarelations@xherald.com.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.